Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Looking at Emerging Trends in Telemedicine
Posted on December 17th, 2020 by Thea Howe in Pharma R&D
Telemedicine, once an intriguing proposition struggling to reach its potential, became an absolute necessity in 2020. In the early days of COVID-19, as medical centers labored to deal with an influx of patients while also trying to mitigate coronavirus spread, telemedicine was urgently needed as an option for providing healthcare to others at a safe distance. In the U.S., the government and providers quickly started to take measures to facilitate its use during the crisis of the pandemic.
In some ways it’s hard to understand why telemedicine wasn’t already in widespread use, though, considering that people are increasingly preferring to do everything from banking to grocery shopping online. Why not healthcare as well?
A new webinar, Emerging Trends in Telemedicine, offers some insight. Moderated by Elsevier’s Ann Gabriel, the webinar includes an international panel featuring Dr. Amol Navathe (Philadelphia VA Medical Center, University of Pennsylvania), Dr. Heather Ross (Toronto General Hospital, University of Toronto), and Dr. Robin Ohannessian (Public Health specialist, Director of Télémédecine 360).
In this fascinating discussion, the panelists talk about the many challenges of telemedicine, which include hurdles like regulatory standards, privacy and security concerns, the need for political buy-in, insurance coverage and pricing for telemedicine visits, and technology requirements. These issues and more have contributed to the relatively sluggish rate of adoption of telemedicine prior to the pandemic.
The good news is that is changing – and while those hurdles are still high, they are hardly insurmountable. The panelists reveal some of the ways that they have seen governments, doctors, patients and the healthcare system as a whole start to embrace telemedicine and they offer some thoughts as to how it can be most effectively used.
The webinar also includes the presentation of some fascinating data and polling results that offer further insight into the latest trends around telemedicine and its adoption.
To learn more, watch the webinar here.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Project Manager at Elsevier Life Sciences Professional Services
Connect on LinkedIn
- COVID-19 Treatment Trial Reaches Out to Communities of Color
- Harris Poll Finds Large Boost in Pharma Industry Reputation
- What Excites You Most About the Life Sciences Industry in 2021?
- How to Use Reaxys Reaction Data to Create Chemistry Models
- What Were the Biggest Advances in Life Sciences in 2020?